We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Mitsubishi Pharma Sign Agreement on 2D Gel Image Analysis
News

Mitsubishi Pharma Sign Agreement on 2D Gel Image Analysis

Mitsubishi Pharma Sign Agreement on 2D Gel Image Analysis
News

Mitsubishi Pharma Sign Agreement on 2D Gel Image Analysis

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Mitsubishi Pharma Sign Agreement on 2D Gel Image Analysis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Ludesi AB has announced that Mitsubishi Pharma in Yokohama, Japan after thorough testing has selected Ludesi for its image analysis processing of 2D gels.

Mitsubishi Pharma Corporation has contracted Ludesi for image analysis of twodimensional protein gels (2D gels), one of the fundamental technologies in proteomics.

"We are proud that Mitsubishi Pharma has selected Ludesi’s technology for 2D gel image analysis, and we look forward to working together in the years to come," commented Ludesi’s CEO Ola Forsstrom-Olsson.

"It is an honor to serve Mitsubishi Pharma’s skilled scientists with top-notch quality in this important proteomics technology."

Experts at Mitsubishi Pharma Corporation tested Ludesi’s system thoroughly and concluded that Ludesi’s offering provided an increased quality and reliability compared to other software systems on the market.

Advertisement